We are live on ! Find out more
IRD

Opus Genetics
IRD

43 hedge funds and large institutions have $4.38M invested in Opus Genetics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more call options, than puts

Call options by funds: $19K | Put options by funds: $2K

100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 6

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

32% more capital invested

Capital invested by funds: $3.32M → $4.38M (+$1.06M)

13% more funds holding

Funds holding: 38 → 43 (+5)

1.99% more ownership

Funds ownership: 9.66% → 11.65% (+2%)

Holders
43
Holders Change
+5
Holders Change %
+13.16%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
14
Increased
12
Reduced
6
Closed
8
Calls
$19K
Puts
$2K
Net Calls
+$17K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Voss Capital
Texas
+$219K
2
Citadel Advisors
Citadel Advisors
Florida
+$102K
3
Renaissance Technologies
Renaissance Technologies
New York
+$86K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$47.9K
5
AWM
Apollon Wealth Management
South Carolina
+$32.2K

Top Sellers

Rank Fund Capital Flow
1
RB
Richmond Brothers
Michigan
-$204K
2
KCM
Knoll Capital Management
Florida
-$115K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$65.2K
4
BCM
Bridgeway Capital Management
Texas
-$56.5K
5
Morgan Stanley
Morgan Stanley
New York
-$31.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFC
26
Bedel Financial Consulting
Indiana
$18.1K – – –
Raymond James Financial
27
Raymond James Financial
Florida
$17.8K +$17.2K +14,980 New
Osaic Holdings
28
Osaic Holdings
Arizona
$16.5K -$6 -5 -0%
SFO
29
Stokes Family Office
Louisiana
$14.4K – – –
Millennium Management
30
Millennium Management
New York
$14.3K +$13.8K +11,991 New
RIP
31
Reliant Investment Partners
North Carolina
$11.9K +$11.5K +10,000 New
TRCT
32
Tower Research Capital (TRC)
New York
$4.87K +$816 +711 +21%
Wells Fargo
33
Wells Fargo
California
$3.31K -$5 -4 -0.1%
National Bank of Canada
34
National Bank of Canada
Quebec, Canada
$2.4K – – –
CWM
35
CarsonAllaria Wealth Management
Illinois
$1.19K – – –
EB
36
Eastern Bank
Massachusetts
$1.19K – – –
MCM
37
MAI Capital Management
Ohio
$1.19K +$1.15K +999 New
Bank of America
38
Bank of America
North Carolina
$288 +$46 +40 +20%
RMP
39
Richards, Merrill & Peterson
Washington
$83 +$80 +70 New
KCM
40
Knoll Capital Management
Florida
$53 -$115K -99,955 -100%
Northwestern Mutual Wealth Management
41
Northwestern Mutual Wealth Management
Wisconsin
$12 +$11 +10 New
Fidelity Investments
42
Fidelity Investments
Massachusetts
$1 +$1 +1 New
RB
43
Richmond Brothers
Michigan
– -$204K -155,620 Closed
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$65.2K -49,755 Closed
VF
45
Virtu Financial
New York
– -$31K -23,728 Closed
PCM
46
Prelude Capital Management
New York
– -$15.9K -12,110 Closed
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
– -$15K -11,739 Closed
Barclays
48
Barclays
United Kingdom
– -$2.49K -1,900 Closed
HI
49
Harbour Investments
Wisconsin
– -$52 -40 Closed
FWM
50
FSA Wealth Management
Massachusetts
– -$7 -5 Closed
1
2
3

IRD Hedge Fund Activity: Q4 2024 in Review

43 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2024, worth a combined $4.38M — up 32% from $3.32M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IRD positions and 8 closed out — a net gain of 6 holders — while 12 added to existing stakes and 6 trimmed.

The largest buyer was Voss Capital, opening a new position worth an estimated $219K. The largest seller was Richmond Brothers, exiting entirely with an estimated $204K sold.

  • 43 institutional investors held Opus Genetics (IRD) as of Q4 2024, up from 38 in Q3 2024.
  • Funds reported $4.38M of Opus Genetics stock for Q4 2024, up 32% quarter-over-quarter.
  • 14 funds opened new Opus Genetics positions in Q4 2024 and 8 closed out, a net change of +6 holders.
  • The largest Opus Genetics buyer in Q4 2024 was Voss Capital, an estimated $219K added.
  • The largest Opus Genetics seller in Q4 2024 was Richmond Brothers, an estimated $204K sold.

Based on aggregated 13F filings for Q4 2024.